IRVINE, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests addressing unmet clinical needs, is ...
IRVINE, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), is a leading developer of precision diagnostic tests that address unmet clinical needs, is ...
IRVINE, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, is ...
The Clinical Frailty Scale assessment can be performed in less than a minute and indicates likelihood of post-surgical mortality and loss of independence. Prior to vascular surgery, an easy nine-point ...
On the heels of a groundbreaking FDA approval for a major medtech, a Silicon Valley startup is shaping up to be a possible competitor. R3 Vascular recently raised $87 million in venture capital cash ...
(MENAFN- GlobeNewsWire - Nasdaq) IRVINE, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC ., (“MSL” or“the Company”), a leading developer of precision diagnostic tests that ...
(MENAFN- GlobeNewsWire - Nasdaq) IRVINE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC ., (“MSL” or“the Company”), a leading developer of precision diagnostic tests that ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈